Literature DB >> 1968523

Urinary neopterin concentrations and T-cell subset data in HIV-1 infection.

G Reibnegger1, D Fuchs, J J Goedert, A Hausen, A Krämer, E R Werner, G Werner-Felmayer, M P Dierich, H Wachter.   

Abstract

We investigated the ability of urinary neopterin concentrations and T-cell subset data, and their ratios to discriminate between anti-HIV-1 seronegatives, seropositives, and AIDS cases. Using receiver-operated-characteristics curves, neopterin levels were shown to provide the best discrimination. Of the ratios derived from the single variables, neopterin per CD4+ cell counts and neopterin per CD4+/CD8+ cell ratio were superior to the CD4+/CD8+ cell ratio. Multivariate analyses were performed using a generalized likelihood ratio approach as well as linear discriminant analysis. The combination of neopterin concentration and CD4+ T-cell count is well suited to discriminate between various stages of HIV-1 infection and, therefore, we recommend using more than one assay to evaluate disease progression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968523     DOI: 10.1007/bf01648890

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

Review 1.  Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application.

Authors:  H Wachter; D Fuchs; A Hausen; G Reibnegger; E R Werner
Journal:  Adv Clin Chem       Date:  1989       Impact factor: 5.394

2.  Generalized likelihood ratio concept and logistic regression analysis for multiple diagnostic categories.

Authors:  G Reibnegger; D Fuchs; A Hausen; E R Werner; G Werner-Felmayer; H Wachter
Journal:  Clin Chem       Date:  1989-06       Impact factor: 8.327

3.  Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS.

Authors:  R N Melmed; J M Taylor; R Detels; M Bozorgmehri; J L Fahey
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

4.  Generalization of the likelihood ratio concept for diagnostic tests with multiple diagnostic categories.

Authors:  G Reibnegger; D Zuchs; A Hausen; E R Werner; G Werner-Felmayer; H Wachter
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

5.  Serum neopterin levels as predictor of AIDS.

Authors:  J R Bogner; A Matuschke; B Heinrich; E Eberle; F D Goebel
Journal:  Klin Wochenschr       Date:  1988-10-17

6.  Decreased helper T lymphocytes in homosexual men. II. Sexual practices.

Authors:  J J Goedert; R J Biggar; D M Winn; D L Mann; D P Byar; D M Strong; R A DiGioia; R J Grossman; W C Sanchez; R G Kase
Journal:  Am J Epidemiol       Date:  1985-05       Impact factor: 4.897

7.  On the use and computation of likelihood ratios in clinical chemistry.

Authors:  A Albert
Journal:  Clin Chem       Date:  1982-05       Impact factor: 8.327

8.  Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection.

Authors:  D Fuchs; T J Spira; A Hausen; G Reibnegger; E R Werner; G W Felmayer; H Wachter
Journal:  Clin Chem       Date:  1989-08       Impact factor: 8.327

9.  Decreased helper T lymphocytes in homosexual men. I. Sexual contact in high-incidence areas for the acquired immunodeficiency syndrome.

Authors:  J J Goedert; R J Biggar; D M Winn; D L Mann; D P Byar; D M Strong; R A DiGioia; R J Grossman; W C Sanchez; R G Kase
Journal:  Am J Epidemiol       Date:  1985-05       Impact factor: 4.897

10.  Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age.

Authors:  M E Eyster; M H Gail; J O Ballard; H Al-Mondhiry; J J Goedert
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

View more
  1 in total

1.  Correlation of the percentage of activated, CD3 + DR + lymphocytes to serum neopterin level in HIV-seropositive haemophiliacs.

Authors:  K Pálóczi; E Ujhelyi; D Fuchs; R Mihalik; D Bánhegyi; S Berkessy; V Salavecz; H Wachter; S R Hollán; G Füst
Journal:  Klin Wochenschr       Date:  1991-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.